This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertazzoni Minelli, E.
Right arrow Articles by Pederzoli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertazzoni Minelli, E.
Right arrow Articles by Pederzoli, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2008, p. 4149-4152, Vol. 52, No. 11
0066-4804/08/$08.00+0     doi:10.1128/AAC.00509-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Piperacillin-Tazobactam Penetration into Human Pancreatic Juice{triangledown}

Elisa Bertazzoni Minelli,1* Anna Benini,1 Luigina Franco,1 Claudio Bassi,2 and Paolo Pederzoli2

Departments of Medicine and Public Health, Pharmacology Section,1 Surgical and Gastroenterological Sciences, University of Verona, Verona, Italy2

Received 18 April 2008/ Returned for modification 2 July 2008/ Accepted 9 September 2008

Piperacillin-tazobactam was administered as a single dose (4.5 g intravenous) to five patients with stabilized external pancreatic fistula. The penetration into pancreatic juice was prompt, and inhibitory concentrations were achieved and maintained for different periods (0.5 to 6 h) according to bacterial susceptibility and patients' characteristics. Piperacillin and tazobactam showed superimposable pharmacokinetics in both serum and pancreatic juice.


* Corresponding author. Mailing address: Department of Medicine and Public Health, Pharmacology Section, Policlinico G. B. Rossi, P.le LA Scuro, 37134 Verona, Italy. Phone: 39 045 8027603. Fax: 39 045 8027452. E-mail: elisa.bertazzoni{at}univr.it

{triangledown} Published ahead of print on 22 September 2008.


Antimicrobial Agents and Chemotherapy, November 2008, p. 4149-4152, Vol. 52, No. 11
0066-4804/08/$08.00+0     doi:10.1128/AAC.00509-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.